Accelerated Cholecystectomy for Gallbladder Inflammation
(FAST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the timing of gallbladder removal surgery (cholecystectomy) for individuals with gallbladder inflammation caused by gallstones. It compares immediate surgery after diagnosis with the usual timing, which can be up to six weeks later. The trial aims to determine if faster surgery results in better outcomes, such as fewer complications and shorter hospital stays. Suitable candidates for this trial have been diagnosed with gallbladder inflammation, require surgery, and experience symptoms like upper right belly pain or fever. As an unphased trial, it provides patients the opportunity to contribute to understanding the optimal timing for surgery to improve health outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are on therapeutic anticoagulation that cannot be reversed, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that having gallbladder removal surgery sooner can lead to better outcomes by reducing the time patients spend in harmful conditions, such as inflammation. Patients who undergo the surgery earlier often experience fewer complications and shorter hospital stays.
For safety, earlier surgery is generally well-tolerated. It is a common procedure and has been performed safely for many years. While all surgeries carry risks, evidence suggests that earlier surgery might lower overall risks.
Overall, the safety of earlier surgery is comparable to waiting, but it may result in a quicker recovery and fewer complications.12345Why are researchers excited about this trial?
Researchers are excited about the accelerated cholecystectomy approach because it aims to perform gallbladder removal surgery within just 6 hours of diagnosing cholecystitis, which is an inflammation of the gallbladder. Traditionally, patients might experience delays in surgery due to scheduling and preparation, which can prolong discomfort and the risk of complications. By speeding up the timeline, the accelerated method could potentially reduce hospital stays, lower the chance of complications, and improve recovery times for patients. This swift intervention is what sets it apart from the standard of care, offering a quicker path to relief and recovery.
What evidence suggests that accelerated cholecystectomy might be an effective treatment for gallbladder inflammation?
Research has shown that prompt gallbladder removal surgery may lead to better outcomes for people with acute cholecystitis, an inflammation of the gallbladder. In this trial, participants in the FAST intervention arm will undergo surgery as soon as possible, aiming for surgery within 6 hours of diagnosis. Studies have found that immediate surgery reduces harmful bodily responses, such as inflammation, and helps prevent complications. Early surgery also appears to lower the risk of bile duct injuries and other issues that can arise from delayed treatment. Although current evidence comes from smaller studies, early findings suggest that faster surgery could result in shorter hospital stays and lower overall costs. This trial further investigates whether this approach consistently provides these benefits.12356
Who Is on the Research Team?
Flavia Kessler Borges PhD, M.D
Principal Investigator
Population Health Research Institute
Rahima Nenshi Msc, M.D
Principal Investigator
St. Joseph's Health Care London
PJ Devereaux PhD, M.D
Principal Investigator
Hamilton Health Sciences Corporation
Are You a Good Fit for This Trial?
This trial is for adults over 45, or those 18-44 with diabetes or chronic heart, lung, or kidney disease. They must have gallbladder inflammation diagnosed by specific symptoms and tests, need surgery during working hours, and stay in the hospital overnight post-surgery. Excluded are those previously in this trial, needing urgent surgery for other reasons, on certain blood thinners, with a history of specific clotting disorders or pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo accelerated cholecystectomy surgery as soon as possible with a goal of surgery within 6 hours of diagnosis
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of clinical outcomes and complications
Standard of Care
Participants receive standard care without accelerated surgery, continuing with care as originally provided by the healthcare system
What Are the Treatments Tested in This Trial?
Interventions
- cholecystectomy
Find a Clinic Near You
Who Is Running the Clinical Trial?
P.J. Devereaux
Lead Sponsor
St. Joseph's Health Care London
Collaborator